Figure 4From: Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population Net health benefit acceptability curves. This graph shows the proportion of trials that attained cost-effectiveness for a given strategy for willingness-to-pay thresholds up to $200,000/QALY.Back to article page